Previous 10 | Next 10 |
Cancer-focused biotech Clovis Oncology ( CLVS ) recorded the second biggest intraday gain for the year on heavy volume on Friday after the company’s shareholders voted against a proposal to implement a reverse stock split. More than 98.8M Clovis ( CLVS ) shares chan...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of 2022’s most popular meme stocks is shooting up today. Microcap Clovis Oncology (NASDAQ: CLVS ) has spiked by 30% as of this writing. Although its gains appear to be tapering off, it is hard to ignore thi...
Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...
Clovis Oncology ( NASDAQ: CLVS ), a biotech focused anti-cancer agents, added more than 34% on Friday to reach the highest level since April after the company’s shareholders rejected a proposal to implement a reverse stock split. Disclosing the outcome of its 20...
Shares of Clovis Oncology (NASDAQ: CLVS) were skyrocketing 41.9% higher at 11:12 a.m. ET on Friday. The huge gain came after the company reported the voting results on three proposals following the market close on Thursday. Clovis' annual shareholder meeting was adjourned on Jun...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clovis Oncology (NASDAQ: CLVS ) stock is rising 5% in early trading after Clovis’ shareholders decided to reject a proposal for a reverse split of the company’s shares. The drug maker’s shar...
Gainers: MyMD Pharmaceuticals ( MYMD ) +23% . Clovis Oncology ( CLVS ) +22% . iRhythm Technologies ( IRTC ) +22% . Acer Therapeutics ( ACER ) +15% . Atreca ( BCEL ) +12% . Losers: RAPT Therapeutics ( RAPT ) -9% ...
Clovis Oncology (NASDAQ: CLVS) , a biopharmaceutical company that specializes in solid-tumor therapies, saw its shares skyrocket 158.9% in June, according to data from S&P Global Intelligence . The stock closed at $0.6953 a share on May 31 and dropped to $0.6367 on June 2. I...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: JJava Designs / Shutterstock Meme stocks are a hot topic among traders on Thursday as investors react to recent news from AMC Entertainment (NYSE: AMC ) and GameStop (NYSE: GME ). Starting with A...
Shares of the small-cap cancer-treatment company Clovis Oncology (NASDAQ: CLVS) are having a rather volatile session today. The drugmaker's shares dropped by as much as 12.8% immediately out of the gate this morning, but have since clawed their way back. As of 11:05 a.m. ET Thursday...
News, Short Squeeze, Breakout and More Instantly...
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...